PropertyValue
?:abstract
  • There is a vital need for authentic COVID-19 animal models to enable the pre-clinical evaluation of candidate vaccines and therapeutics. Here we report a dose titration study of SARS-CoV-2 in the ferret model. After a high (5 × 10(6) pfu) and medium (5 × 10(4) pfu) dose of virus is delivered, intranasally, viral RNA shedding in the upper respiratory tract (URT) is observed in 6/6 animals, however, only 1/6 ferrets show similar signs after low dose (5 × 10(2) pfu) challenge. Following sequential culls pathological signs of mild multifocal bronchopneumonia in approximately 5–15% of the lung is seen on day 3, in high and medium dosed groups. Ferrets re-challenged, after virus shedding ceased, are fully protected from acute lung pathology. The endpoints of URT viral RNA replication & distinct lung pathology are observed most consistently in the high dose group. This ferret model of SARS-CoV-2 infection presents a mild clinical disease.
?:creator
?:doi
  • 10.1038/s41467-020-20439-y
?:doi
?:journal
  • Nat_Commun
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/c8aa1b8e8c857530af675cc786133d5ffb34f925.json; document_parses/pdf_json/5b7871d782a58d263d85e3effadcf5f698762d56.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7782478.xml.json
?:pmcid
?:pmid
?:pmid
  • 33398055.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity
?:type
?:year
  • 2021-01-04

Metadata

Anon_0  
expand all